SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006065
Filing Date
2021-05-06
Accepted
2021-05-06 07:12:08
Documents
83
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bcyc-20210331x10q.htm 10-Q 1710205
2 EX-31.1 bcyc-20210331ex31103dad5.htm EX-31.1 14137
3 EX-31.2 bcyc-20210331ex3124e6902.htm EX-31.2 14154
4 EX-32.1 bcyc-20210331ex321559bb1.htm EX-32.1 10847
  Complete submission text file 0001558370-21-006065.txt   7234074

Data Files

Seq Description Document Type Size
5 EX-101.INS bcyc-20210331.xml EX-101.INS 1413161
6 EX-101.SCH bcyc-20210331.xsd EX-101.SCH 72533
7 EX-101.CAL bcyc-20210331_cal.xml EX-101.CAL 50684
8 EX-101.DEF bcyc-20210331_def.xml EX-101.DEF 243928
9 EX-101.LAB bcyc-20210331_lab.xml EX-101.LAB 543626
10 EX-101.PRE bcyc-20210331_pre.xml EX-101.PRE 428733
Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38916 | Film No.: 21895754
SIC: 2834 Pharmaceutical Preparations